Harvard Bioscience (HBIO) Deferred Taxes (2010 - 2019)

Harvard Bioscience (HBIO) has 10 years of Deferred Taxes data on file, last reported at $42000.0 in Q3 2019.

• On a quarterly basis, Deferred Taxes fell 74.07% year-over-year to $42000.0 in Q3 2019; TTM through Sep 2019 was -$2.9 million, a 90.12% decrease from a year earlier, with the FY2018 full-year figure at -$2.9 million, down 80.62% from the prior year.
• Deferred Taxes for Q3 2019 stood at $42000.0, up from -$1000.0 in the prior quarter.
• Over the last five years, Deferred Taxes for HBIO reached as high as $16.1 million in Q4 2015 and fell as low as -$2.9 million in Q4 2018.
• Historically, Deferred Taxes has averaged $745214.3 across 5 years, with a median of $1000.0 in 2015.
• Across the five-year window, Deferred Taxes plunged 1019.05% in 2015 and surged 14933.33% in 2016, its largest moves.
• Year by year, Deferred Taxes stood at $16.1 million in 2015, then tumbled by 104.55% to -$734000.0 in 2016, then sank by 115.8% to -$1.6 million in 2017, then sank by 84.79% to -$2.9 million in 2018, then surged by 101.43% to $42000.0 in 2019.
• Per Business Quant data, the three most recent Deferred Taxes figures were $42000.0 in Q3 2019, -$1000.0 in Q1 2019, and -$2.9 million in Q4 2018.